SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

CStone Reports CS2009 Clinical Data From More Than 300 Patients

CStone said data presented at ESMO 2026 support CS2009’s mechanism, safety and broad antitumor activity.

CSTONE

Related stories